G

Genmab

Develops and licenses antibody cancer therapeutics

Associate Director - Global Drug Safety & Pharmacovigilance Scientist

Biology & BiotechConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USA

About the Job

Requirements

  • A Health Care Professional degree is required, such as RN/BSN/MSN, NP, PA, or PharmD, and at least 5 years of pharmaceutical industry experience in drug safety and pharmacovigilance as a Safety Scientist for products in clinical trial and post-marketing environments.
  • Experience authoring safety signal assessment reports, DSUR, PBRER, RMP, and RSI.
  • Skill in signal detection processes and managing safety information from clinical development and post-marketing sources.
  • Experience with FDA and EMA regulations and ICH guidance governing pharmacovigilance and risk management.
  • Knowledge of the drug development process, pharmacovigilance databases, and MedDRA coding.
  • Experience using safety databases; Argus Safety Database experience is preferred.
  • Documented experience overseeing multiple trials with global-level safety inputs.
  • International experience in a similar role with internal and external stakeholders.
  • Excellent written and spoken English communication skills.
  • Ability to build professional relationships with collaborators and business partners.
  • Ability to proactively prioritize work in a fast-paced, changing environment.
  • Ability to work toward results and goals and contribute to organizational success.

Responsibilities

  • Contribute to safety strategy and safety deliverables for assigned programs in collaboration with stakeholders in Global Drug Safety and Pharmacovigilance and other cross-functional teams.
  • Perform ongoing surveillance, including signal detection and evaluation, of clinical trial and post-marketing safety data.
  • Serve as the primary safety contact for other departments and ensure appropriate, timely handling of safety issues for assigned trials and programs.
  • Review and provide safety input on trial protocols, electronic and paper case report forms, and trial master files.
  • Contribute to development of Investigator’s Brochures and subject informed consent documents.
  • Contribute to health authority requests and review key submission documents.
  • Contribute to product safety documentation throughout the product lifecycle, from first-in-human trials through post-marketing, including safety surveillance, safety assessment reports for potential signals or risks, RSI in Investigator’s Brochures, ADR in the CCDS and product labels, aggregate safety reports such as DSUR, PBRER, PSUR, and PAER, risk management plans, and responses to ad hoc internal and external safety information requests.
  • Contribute to planning and conducting Safety Committee activities and Data Monitoring Committees.
  • Conduct safety training for employees, contract research organizations, investigators, and relevant site personnel as needed.
  • Contribute to multidisciplinary project groups, including serving on the Clinical Management Team for assigned products.
  • Contribute to developing and optimizing tools and processes.
  • Interact with safety and clinical contract research organizations, oversee sponsor safety-related tasks, process invoices, and ensure regulatory compliance, including reporting requirements, for assigned products.
  • Support review of Safety Data Exchange Agreements with partners as needed.
  • Collaborate with external experts and partners.
  • Monitor new and updated regulations and guidelines and assess their impact on drug safety processes.
  • Ensure compliance with regulatory guidelines and internal procedures in preparation for audits and inspections.
  • Participate in audit and inspection activities as required.
  • Perform other duties as assigned.

Desired Qualifications

  • Experience in oncology and/or first-in-human trials.

About the Company

Genmab

Develops and licenses antibody cancer therapeutics

Genmab develops antibody-based therapies to treat cancer. The company discovers, develops, and commercializes proprietary antibody technologies and treatments designed to target and kill cancer cells, often in collaboration with other biotech or pharmaceutical partners. Its products work by using antibodies that recognize specific cancer cell markers, helping the immune system or the drugs attack and destroy those cells. Genmab differentiates itself through its own patented antibody platforms and its focus on strategically partnering for development and commercialization, allowing it to leverage scientific expertise and shared resources rather than relying on a single product. The company aims to turn scientific insights into approved cancer medicines that improve patient outcomes while building value through licensing deals and collaborations with researchers and drug developers around the world.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Copenhagen, Denmark
Founded
1999

Recently Posted Jobs

Explore more opportunities at Genmab

See more jobs